Skip to main content

Table 4 Association of disease control rate (DCR) with examined biomarkers

From: Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer

  

Response

  

Disease control

Disease progression

p-value

  

N (%)

N (%)

 

Gene status

    

KRAS (N=30)

WT

7 (0)

20 (87)

0.999

 

Mutated

0 (0)

3 (13)

 

EGFR (N=33)

WT

1 (17)

21 (78)

0.010

 

Mutated

5 (83)

6 (22)

 

IHC

    

EGFR (HIRSCH) (N=45)

Negative

8 (73)

30 (88)

0.337

 

Positive

3 (27)

4 (12)

 

pEGFR (N=43)

Negative

4 (36)

15 (47)

0.728

 

Positive

7 (64)

17 (53)

 

cMET (N=42)

Negative

5 (50)

17 (53)

0.999

 

Positive

5 (50)

15 (47)

 

FISH

    

EGFR (N=45)

Negative

5 (56)

34 (94)

0.005

 

High polysomy

2 (22)

0 (0)

 
 

Amplified

2 (22)

2 (6)

 

EGFR (N=45)

Negative

5 (56)

34 (94)

0.010

 

Positive

4 (44)

2 (6)

 

D7S486 (N=37)

Deletion

3 (43)

12 (40)

0.999

 

Normal

4 (57)

18 (60)

 

MET (N=43)

Negative

11 (100)

31 (97)

0.999

 

Positive

0 (0)

1 (3)